Next earnings date: 4 Nov 2025
Cencora – NYSE:COR
Cencora stock price today
$293
+66.07
+29.11%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in about 6 hours
Cencora stock price monthly change
+1.95%
month
Cencora stock price quarterly change
+1.95%
quarter
Cencora stock price yearly change
+11.12%
year
Cencora key metrics
Market Cap | 43.60B |
Enterprise value | 45.11B |
P/E | 29.51 |
EV/Sales | 0.15 |
EV/EBITDA | 13.54 |
Price/Sales | 0.14 |
Price/Book | 68.95 |
PEG ratio | -3.21 |
EPS | 8.37 |
Revenue | 267.74B |
EBITDA | 3.98B |
Income | 1.68B |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0.51% |
Oper. margin | 0.84% |
Gross margin | 3.06% |
EBIT margin | 0.84% |
EBITDA margin | 1.49% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeCencora stock price history
Cencora stock forecast
Cencora financial statements
| Mar 2023 | 63.45B | 435.40M | 0.69% |
|---|---|---|---|
| Jun 2023 | 66.94B | 479.58M | 0.72% |
| Sep 2023 | 68.92B | 350.56M | 0.51% |
| Mar 2024 | 68.41B | 420.77M | 0.62% |
| Sep 2025 | 80.86B | 713.94M | 0.88% |
|---|---|---|---|
| Dec 2025 | 80.68B | 778.91M | 0.97% |
| Dec 2025 | 81.17B | 772.78M | 0.95% |
| Mar 2026 | 78.99B | 909.11M | 1.15% |
Analysts Price target
Financials & Ratios estimates
0.91%
Yield TTM
| Payout ratio | 27.58% |
|---|
| 2020 | 1.73% |
|---|---|
| 2021 | 1.49% |
| 2022 | 1.39% |
| 2023 | 1.09% |
| 2024 | 0.93% |
| Mar 2023 | 58766183000 | 58.25B | 99.13% |
|---|---|---|---|
| Jun 2023 | 61177196000 | 60.25B | 98.49% |
| Sep 2023 | 62558746000 | 61.89B | 98.93% |
| Mar 2024 | 63868046000 | 62.64B | 98.08% |
| Mar 2023 | 629.50M | -88.73M | -769.44M |
|---|---|---|---|
| Jun 2023 | 744.93M | -819.12M | -81.87M |
| Sep 2023 | 1.82B | -183.44M | -407.01M |
| Mar 2024 | -878.44M | -166.48M | 323.17M |
Cencora alternative data
| Aug 2023 | 480 |
|---|---|
| Sep 2023 | 480 |
| Oct 2023 | 46,000 |
| Nov 2023 | 46,000 |
| Dec 2023 | 42,000 |
| Jan 2024 | 42,000 |
| Feb 2024 | 42,000 |
| Mar 2024 | 42,000 |
| Apr 2024 | 42,000 |
| May 2024 | 42,000 |
| Jun 2024 | 46,000 |
| Jul 2024 | 46,000 |
Cencora other data
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Feb 2024 | 0 | 4213495 |
| Mar 2024 | 0 | 17732 |
| Apr 2024 | 0 | 68318 |
| May 2024 | 0 | 1870145 |
| Aug 2024 | 0 | 4450398 |
| Sep 2024 | 0 | 21509 |
| Oct 2024 | 0 | 21509 |
| Nov 2024 | 0 | 71509 |
| Dec 2024 | 0 | 3494 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | BATTAGLIA SILVANA officer: Executive Vice President | Common Stock | 1,678 | $228.72 | $383,792 | ||
Option | CLEARY JAMES F officer: Chief Fi.. | Common Stock | 207 | N/A | N/A | ||
Option | CLEARY JAMES F officer: Chief Fi.. | Restricted Stock Units | 207 | N/A | N/A | ||
Option | COLLIS STEVEN H director, officer.. | Common Stock | 395 | N/A | N/A | ||
Option | COLLIS STEVEN H director, officer.. | Restricted Stock Units | 395 | N/A | N/A | ||
Option | KRIKORIAN LAZARUS officer: SVP & Chief Accounting.. | Common Stock | 108 | N/A | N/A | ||
Option | KRIKORIAN LAZARUS officer: SVP & Chief Accounting.. | Restricted Stock Units | 108 | N/A | N/A | ||
Option | MAUCH ROBERT P. director, officer: President & .. | Common Stock | 789 | N/A | N/A | ||
Option | MAUCH ROBERT P. director, officer: President & .. | Restricted Stock Units | 789 | N/A | N/A | ||
Sale | KRIKORIAN LAZARUS officer: SVP & Chief Accounting.. | Common Stock | 1,816 | $250.42 | $454,754 |
| Quarter | Transcript |
|---|---|
| Q2 2024 1 May 2024 | Q2 2024 Earnings Call Transcript |
| Q1 2024 31 Jan 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 4 Nov 2023 | Q4 2023 Earnings Call Transcript |
| Q2 2023 2 May 2023 | Q2 2023 Earnings Call Transcript |
Using SA's Stock Screener: Sell 6 Overvalued Blue Chips, With Stagnating Growth
June 2024 New Analysts Cover Uber, TG Therapeutics, CarMax, And More
Cencora: Long-Term Compounder With Mouth-Watering Economics
Cencora: Continued Economic Value On The Table Across All Investment Horizons
Walgreens Boots Alliance: A Speculative Play At A Price That Makes Sense
Cencora: New Name, Same Old Economic Leverage, Reiterate Buy
Walmart: Ozempic And Its Potential Impact On Grocery Sales
DigitalBridge: 5 Reasons That Would Keep This Amazing Run Alive
Cyxtera: A Compelling Alternative To Equinix And Digital Realty
-
What's the price of Cencora stock today?
One share of Cencora stock can currently be purchased for approximately $293.
-
When is Cencora's next earnings date?
Cencora is estimated to report earnings on Tuesday, 4 Nov 2025.
-
Does Cencora pay dividends?
Yes, Cencora pays dividends and its trailing 12-month yield is 0.92% with 28% payout ratio. The last Cencora stock dividend of $1.27 was paid on 13 Dec 2021.
-
How much money does Cencora make?
Cencora has a market capitalization of 43.60B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 12.12% to 293.96B US dollars.
-
What is Cencora's stock symbol?
Cencora is traded on the NYSE under the ticker symbol "COR".
-
What is Cencora's primary industry?
Company operates in the Healthcare sector and Medical - Distribution industry.
-
How do i buy shares of Cencora?
Shares of Cencora can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Cencora's key executives?
Cencora's management team includes the following people:
- Mr. Paul E. Szurek Pres, Chief Executive Officer & Director(age: 64, pay: $1,530,000)
- Mr. Steven J. Smith Chief Revenue Officer(age: 60, pay: $934,440)
- Mr. Jeffrey S. Finnin Chief Financial Officer & Treasurer(age: 62, pay: $849,450)
- Mr. Derek S. McCandless Senior Vice President of Legal, Gen. Counsel & Sec.(age: 54, pay: $717,730)
- Mr. Brian P. Warren Senior Vice President of Devel. & Product Engineering(age: 55, pay: $557,130)
-
How many employees does Cencora have?
As Jul 2024, Cencora employs 46,000 workers, which is 10% more then previous quarter.
-
When Cencora went public?
Cencora is publicly traded company for more then 30 years since IPO on 4 Apr 1995.
-
What is Cencora's official website?
The official website for Cencora is amerisourcebergen.com.
-
Where are Cencora's headquarters?
Cencora is headquartered at 1 West First Avenue, Conshohocken, PA.
-
How can i contact Cencora?
Cencora's mailing address is 1 West First Avenue, Conshohocken, PA and company can be reached via phone at +61 7277000.
Cencora company profile:
Cencora
amerisourcebergen.comExchange:
NYSE
Full time employees:
46,000
Industry:
Medical - Distribution
Sector:
Healthcare
Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
1 West First Avenue
Conshohocken, PA 19428
Conshohocken, PA 19428
CIK: 0001140859
ISIN: US03073E1055
CUSIP: 03090BBJ8
